8 / 15
Page 40
conferenceseries
.com
Volume 9
Journal of Nutrition & Food Sciences
ISSN: 2155-9600
Clinical Nutrition 2019
March 04-06, 2019
March 04-06, 2019 | Barcelona, Spain
24
th
International Conference on
Clinical Nutrition
Glutamine use in pelvic sarcopenia: A prospective, randomized, placebo controlled, double blind study
Birkan Ilhan
1
, Gulistan Bahat
2
, Nalan Capan
2
, Cihan Kilic
2
, Cenk Yasa
2
, Funda Gungor
2
, Ozlem Persil Ozkan
3
, Ayse Karan
2
and
Mehmet Akif Karan
2
1
Dr. Ersin Arslan Research and Training Hospital, Turkey
2
Istanbul University, Turkey
3
Istanbul Arel University, Turkey
T
he pelvic floor muscles are important in the maintenance of continence. The weakness of muscles may lead
to stress incontinence and facilitate urgency and functional incontinence. We aimed to determine the effect
of additional oral glutamine supplementation to Kegel exercise on pelvic floor strength and clinical parameters
of urinary incontinence in females. Females with urinary incontinence were included. Digital test and a vaginal
manometer were used for measuring the strength of the pelvic floor muscles. Twenty four hours pad weight test
was examined. Participants were randomized into 2 groups as oral glutamine 30 g/day and placebo. It was asked to
use the supplementation and Kegel exercises to all participants for 3 months. Basic and 3rd month measurements
were compared. Also, the progression between measurements at basic and 3rd months was compared. There were
11 patients in the glutamine arm and 18 patients in the placebo arm. Mean age was 58.2±6.6 years. There was no
age difference between the groups [glutamine 59±3.8, placebo 57.8±7.9 years, p>0.05]. In glutamine arm, vaginal
muscle strength assessed by digital test was higher at the end of 3 months [2.9±0.7 vs. 4±0.9; 0-3 months respectively,
p=0.014]; perineometer measurements were not statistically different [27.4±8.3 vs. 31.2±8.9; 0-3 months respectively,
p>0.05]; 24 hour pad weight was not different [p>0.05]. In the placebo arm, there was statistically significant
progress in vaginal muscle strength assessed by both digital test and perineometer and 24-hour pad weight (p values:
0.005, 0.011, and 0.002 respectively). When we compare the progression scores between the groups; there was no
statistically significant difference [p>0.05]. Our study suggests that glutamine supplementation does not provide
additional benefit in the treatment of pelvic muscle sarcopenia in patients without protein-energy-malnutrition.
birkanilhan@hotmail.comJ Nutr Food Sci 2019, Volume 9
DOI: 10.4172/2155-9600-C2-093